Clinical Trials for Bladder Cancer

Find clinical trials for bladder cancer. Discover research opportunities and treatment options in your area.

232 Active Trials Found

Showing 232 trials on this page

Page 4 of 12

Predicting BCG Response

NCT ID: NCT04564781

This clinical trial, called "Predicting BCG Response," is studying a new urine test that aims to help doctors predict how well patients with bladder cancer will respond to a specific treatment know...

Recruiting

Type: observational Locations: Los Angeles, California, United States, Los Angeles, California, United States +2 more

Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer

NCT ID: NCT06389019

This clinical trial is studying a new system that uses advanced computer technology to help doctors predict how long patients with bladder cancer might live after surgery. The goal is to improve tr...

Recruiting

Type: observational Locations: Chongqing, Chongqing, China

Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer

NCT ID: NCT06092450

This clinical trial is studying a new way to predict how well patients with muscle invasive bladder cancer (MIBC) will do after surgery to remove their bladder, known as radical cystectomy. The res...

Recruiting

Type: observational Locations: Chongqing, Chongqing, China

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

NCT ID: NCT03193541

This clinical trial is focused on improving the way bladder cancer is detected in patients who have microscopic hematuria, which means there are small amounts of blood in the urine that can only be...

Recruiting

Type: observational Locations: Rochester, New York, United States, Los Angeles, California, United States +6 more

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

NCT ID: NCT04923178

This clinical trial is looking to learn more about urinary tract cancers, including those that are common, like bladder cancer, as well as rarer types that can affect the kidney, prostate, and test...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Washington, District Of Columbia, United States +1 more

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

NCT ID: NCT03504163

This clinical trial is studying a new treatment approach for patients with high-risk bladder cancer and upper tract urothelial carcinoma. Researchers want to see how effective a combination of two ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +5 more

Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population

NCT ID: NCT06992986

This clinical trial is studying the differences in the bladder microbiome, which is the community of microorganisms in the bladder, among adult men with bladder cancer, those with benign urinary di...

Recruiting

Type: observational Locations: Rome, , Italy

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

NCT ID: NCT03413982

This clinical trial is focused on bladder cancer, aiming to create a registry, which is like a "bank" of information about patients who have this condition. By collecting data from patients, resear...

Recruiting

Type: observational Locations: Kansas City, Kansas, United States

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

NCT ID: NCT06337084

This clinical trial is testing a new imaging agent called MNPR-101-DFO*-89Zr to see how well it can help doctors locate tumors in patients with solid tumors, which can include types of cancer like ...

Recruiting

Phase: PHASE1 Type: interventional Locations: North Melbourne, Victoria, Australia

Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors

NCT ID: NCT06617169

This clinical trial is looking at a new treatment called MNPR-101-PCTA-177Lu for patients with solid tumors, including types of cancer such as bladder, breast, lung, colorectal, gastric, ovarian, a...

Recruiting

Phase: PHASE1 Type: interventional Locations: North Melbourne, Victoria, Australia

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT ID: NCT05837767

This clinical trial is investigating a new type of radiation therapy called lattice radiation therapy (LRT) to see if it works better than the standard approach known as stereotactic body radiation...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, Harrison, New York, United States +5 more

Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy

NCT ID: NCT06986304

This clinical trial is looking at a new way to use ultrasound technology to study bladder cancer. The researchers want to see if a special type of ultrasound, called "Super-Resolution Ultrasound Lo...

Not yet recruiting

Type: observational Locations: Durham, North Carolina, United States

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

NCT ID: NCT03914794

This clinical trial is studying a medication called Pemigatinib to see how well it works for patients with non-muscle invasive bladder cancer (NMIBC) who have had their tumors come back. The trial ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Washington, District Of Columbia, United States, Myrtle Beach, South Carolina, United States +4 more

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

NCT ID: NCT05137262

This clinical trial is studying the effects of a combination treatment for bladder cancer. Specifically, it compares standard chemotherapy to a treatment that includes chemotherapy plus a medicatio...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

NCT ID: NCT06586255

This clinical trial is investigating the safety of combining immunotherapy and radiation therapy for patients with bladder cancer, specifically a type called urothelial carcinoma. It's a Phase I st...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents

NCT ID: NCT06963346

This clinical trial is studying a new treatment approach for patients with muscle invasive bladder cancer (MIBC) who cannot receive standard cisplatin chemotherapy. The researchers want to find out...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States

A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

NCT ID: NCT03193528

This clinical trial is studying a new test called a multiplex ELISA assay, which aims to improve the way we detect bladder cancer (BCa) in patients who have blood in their urine, a condition known ...

Recruiting

Type: observational Locations: Los Angeles, California, United States, Los Angeles, California, United States +4 more

Measuring Surgical Recovery After Radical Cystectomy

NCT ID: NCT03193970

This clinical trial, titled "Measuring Surgical Recovery After Radical Cystectomy," is focused on understanding how patients recover after surgery for bladder cancer. The study aims to gather infor...

Recruiting

Type: observational Locations: Chicago, Illinois, United States, Stanford, California, United States +11 more

Comprehensive Optimization At-time of Radical Cystectomy Intervention

NCT ID: NCT05714826

This clinical trial, called the Comprehensive Optimization At-time of Radical Cystectomy Intervention, is focused on improving care for patients with bladder cancer who are about to undergo a major...

Recruiting

Phase: NA Type: interventional Locations: Dallas, Texas, United States

Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

NCT ID: NCT06957561

This clinical trial is investigating a new treatment approach for patients with muscle-invasive bladder cancer (MIBC) who cannot receive cisplatin chemotherapy. The study is testing a combination o...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions